2025 · 1st Quarter (Jan 1 - Mar 31)

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Filed by BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.).

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 21, 2025
Income: Not reported
Expenses: $190,000.00
Registrant: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Filing UUID: 4dbcfe15-9004-435f-9eef-256a13a39948
Termination date: Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Issues pertaining to NIH research funding H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

Literal federal measure citations: H.R. 1968

HCR · Health Issues

Issues pertaining to NIH research funding Issues pertaining to Medicare coverage of AID and CGM systems H.R. 919, the Chronic Disease Flexible Coverage Act H.R. 1539, the Medical Device Electronic Labeling Act

Literal federal measure citations: H.R. 919, H.R. 1539

TAX · Taxation/Internal Revenue Code

S. 317 / H.R. 801, The Charitable Act

Literal federal measure citations: S. 317, H.R. 801

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.